文献速递脊柱关节炎

磁共振成像评估肿瘤坏死因子抑制剂对青少年中轴型脊柱关节炎骶髂关节的疗效

Measuring the Impact: Magnetic Resonance Imaging Response of Sacroiliac Joints to Tumor Necrosis Factor Inhibitors in Youth With Axial Disease.
PubMed 文献 · Arthritis Rheumatol · 2026-03-19

这项前瞻性多中心研究纳入75例8至18岁中轴型幼年脊柱关节炎患者,在启动TNFi后12周和24周评估骶髂关节MRI炎症与结构病变及患者报告结局。结果显示89%患者SIS改善,63%在12周达炎症缓解,但24周时仍有56%持续炎症,而85%持续炎症者报告临床改善。

要点

  • TNFi治疗后12周内84%的SIS改善已完成,63%患者达炎症缓解(SIS<2)。
  • 12周持续炎症者中85%报告至少中度临床改善,提示影像与症状改善不一致。
  • 24周时56%患者仍有持续炎症,需关注延迟应答者。

核心结论

  • 多数中轴型幼年脊柱关节炎患者对TNFi出现早期影像学应答,大部分改善发生在12周内。
  • 尽管近半数患者残留炎症,多数报告症状改善,提示TNFi快速起效及疗效异质性。

研究设计与样本

  • 前瞻性多中心研究纳入75例8至18岁临床诊断中轴型幼年脊柱关节炎并启动TNFi的患者。
  • 基线及12周评估临床、MRI和患者报告结局,12周持续炎症者在24周复评。
  • 三名盲法评审使用SPARCC骶髂关节炎症评分(SIS)和结构评分评估MRI。

主要发现

  • 73例完成基线访视,62例MRI确诊中轴型幼年脊柱关节炎,57例完成12周随访。
  • 12周时89%(51/57)SIS改善,63%(36/57)达炎症缓解(SIS<2),SIS中位变化为-8(IQR:-18至-3)。
  • 12周持续炎症者(n=26)中85%报告至少中度临床改善;24周时56%(14/25)仍有持续炎症。
  • 84%的SIS改善发生在最初12周内。
  • 至少两次扫描者中,12周时结构病变评分变化(减少/增加/不变):侵蚀58%/25%/18%,硬化21%/9%/70%,脂肪化生0%/30%/70%,回填4%/28%/68%。

关键数值与推荐

  • 炎症缓解定义为SIS<2。
  • SIS中位变化从基线至12周为-8(IQR:-18至-3)。
  • 12周时89%患者SIS改善,63%达炎症缓解。
  • 24周时56%持续炎症者仍有炎症。

临床怎么用

  • TNFi治疗中轴型幼年脊柱关节炎应在12周内评估MRI炎症应答,多数改善在此期间出现。
  • 影像残留炎症不一定伴随症状无改善,临床决策需结合患者报告结局综合判断。

局限性

  • 样本量较小,部分分析基于完成随访的亚组。
  • 24周随访仅限12周持续炎症者,未覆盖全部队列。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the timeline for resolution of sacroiliac joint (SIJ) inflammation, changes in structural lesions, and their correlation with patient-reported outcomes (PROs) in youth with axial juvenile spondyloarthritis (axJSpA) initiating tumor necrosis factor inhibitor (TNFi). METHODS: This prospective, multicenter study included youth aged 8 to 18 years with a clinical diagnosis of axJSpA starting TNFi. Assessments were conducted at baseline and 12 weeks, including clinical evaluation, magnetic resonance imaging (MRI), and PROs. Participants with persistent SIJ inflammation at 12 weeks were reassessed at 24 weeks. Three blinded reviewers evaluated MRIs using Spondyloarthritis Research Consortium of Canada SIJ inflammation scores (SIS) and SIJ structural scores. RESULTS: Of 75 enrolled participants, 73 completed baseline visits, and 62 had MRI-confirmed axJSpA. Fifty-seven completed a 12-week follow-up; 89% (51 of 57) showed SIS improvement, and 63% (36 of 57) achieved inflammation resolution (SIS <2). Median SIS change from baseline to 12 weeks was -8 (interquartile range: -18 to -3). Among those with persistent inflammation at 12 weeks (n = 26), 85% reported at least moderate clinical improvement. At 24 weeks, 56% (14 of 25) had ongoing inflammation. A total of 84% of SIS improvement occurred within the first 12 weeks. In patients with at least two scans, structural lesion scores decreased, increased, or stayed the same from baseline to the 12-week scan for erosions (58%/25%/18%), sclerosis (21%/9%/70%), fat metaplasia (0%/30%/70%), and backfill (4%/28%/68%). CONCLUSION: Most participants showed early imaging response to TNFi, with most improvement occurring within 12 weeks. Despite residual inflammation persisting in nearly half of patients, most reported symptom improvement, underscoring both the rapid impact of TNFi and the heterogeneity of treatment effects.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Brandon TG, Xiao R, Lovell DJ, et al. Measuring the Impact: Magnetic Resonance Imaging Response of Sacroiliac Joints to Tumor Necrosis Factor Inhibitors in Youth With Axial Disease. Arthritis Rheumatol. 2026. PMID: 41457704. doi:10.1002/art.70050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。